He talks about the recent advancements in the distribution of cells in human tissues that primarily mediate the abnormalities in cystic fibrosis, how these advancements have influenced treatment...
He discusses the need for rapid, efficient development of vaccines for emerging infectious diseases, the 3-prong approach for staying ahead of the curve, and more.
Findings from a new study highlight the gaps in the UNAIDS 90-90-90 targets that are not being bridged. Lead author James Stannah, MPH, answers our questions about his study and how the target can be...
He discusses his latest research on the effects of tesamorelin use on non-alcoholic fatty liver disease (NAFLD) in patients with HIV, how the increase in obesity among patients with HIV affects the risk for...
He discusses his latest research on the effects of tesamorelin use on non-alcoholic fatty liver disease (NAFLD) in patients with HIV, how the increase in obesity among patients with HIV affects the risk for...
He discusses the biomarkers in the pipeline for diagnosing infectious diseases, including tuberculosis and sepsis, and details which ones are most likely to make it to clinical practice.
She talks about what we have learned from the Zika outbreak in Rio de Janeiro in 2015 and what research is being done to protect against the virus in endemic areas, a topic she also spoke about at IDWeek...
A new study evaluated the accuracy of a LAM-based point-of-care test for diagnosing tuberculosis in patients with HIV. Lead author Claudia Denkinger, MD, PhD, answered our questions.
